Ondansetron Eql Pharma

Ondansetron, the active ingredient in Ondansetron Eql Pharma, is a 5-HT3 receptor antagonist presented as a strength/form for oral use. It helps prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery in adult and pediatric patients. GNH USA supplies Ondansetron Eql Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Eql Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron is a selective 5‑HT3 receptor antagonist that is used across the nausea‑vomiting pathway to prevent and treat se ​     after chemotherapy : - Chemotherapy‑induced NVI : Prevents the onset of vom  after radi : - Radiation‑  : - Radi  a : -  a :

Common  t 

t

t